WoutersOJShadlenKCSalcher-KonradM, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023-1034. doi:10.1016/S0140-6736(21)00306-8.
3.
HussainATahirAHussainZ, et al. Artificial intelligence-enabled analysis of public attitudes on Facebook and Twitter toward COVID-19 vaccines in the United Kingdom and the United States: observational study. J Med Internet Res. 2021;23(4):e26627. doi:10.2196/26627.
4.
AlwiSSRafidahEZurrainiAJuslinaOBrohiIBLukasS. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129. doi:10.1186/s12889-021-11071-6.
5.
LazarusJRatzanSPalayewA, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2020;27(2):225-228.
6.
CallowMACallowDD. Older adults’ behaviour intentions once a COVID-19 vaccine becomes available. J Appl Gerontol. 2021;40:943-952. doi:10.1177/07334648211019205.
7.
WongMCWongELHuangJ, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021;39(7):1148-1156. doi:10.1016/j.vaccine.2020.12.083.
8.
ShermanSMSmithLESimJ, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccines Immunother. 2021;17(6):1612-1621. doi:10.1080/21645515.2020.1846397.
9.
SonawaneKTroisiCLDeshmukhAA. COVID-19 vaccination in the UK: addressing vaccine hesitancy. Lancet Reg Health Eur. 2021;1:100016. doi:10.1016/j.lanepe.2020.100016.